{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:18:24Z","timestamp":1793053104545,"version":"4.5.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1949,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      <jats:bold>Progressive familial intrahepatic cholestasis (PFIC) types 1 and 2 are characterized by normal serum gamma-glutamyl transferase (GGT) activity and are due to mutations in<\/jats:bold>\n                      <jats:bold>ATP8B1<\/jats:bold>\n                      <jats:bold>(encoding FIC1) and<\/jats:bold>\n                      <jats:bold>ABCB11<\/jats:bold>\n                      <jats:bold>(encoding bile salt export pump [BSEP]), respectively. Our goal was to evaluate the features that may distinguish PFIC1 from PFIC2 and ease their diagnosis. We retrospectively reviewed charts of 62 children with normal-GGT PFIC in whom a search for<\/jats:bold>\n                      <jats:bold>ATP8B1<\/jats:bold>\n                      <jats:bold>and\/or<\/jats:bold>\n                      <jats:bold>ABCB11<\/jats:bold>\n                      <jats:bold>mutation, liver BSEP immunostaining, and\/or bile analysis were performed. Based on genetic testing, 13 patients were PFIC1 and 39 PFIC2. The PFIC origin remained unknown in 10 cases. PFIC2 patients had a higher tendency to develop neonatal cholestasis. High serum alanine aminotransferase and alphafetoprotein levels, severe lobular lesions with giant hepatocytes, early liver failure, cholelithiasis, hepatocellular carcinoma, very low biliary bile acid concentration, and negative BSEP canalicular staining suggest PFIC2, whereas an absence of these signs and\/or presence of extrahepatic manifestations suggest PFIC1. The PFIC1 and PFIC2 phenotypes were not clearly correlated with mutation types, but we found tendencies for a better prognosis and response to ursodeoxycholic acid (UDCA) or biliary diversion (BD) in a few children with missense mutations. Combination of UDCA, BD, and liver transplantation allowed 87% of normal-GGT PFIC patients to be alive at a median age of 10.5 years (1-36), half of them without liver transplantation.<\/jats:bold>\n                      <jats:bold>Conclusion:<\/jats:bold>\n                      <jats:bold>PFIC1 and PFIC2 differ clinically, biochemically, and histologically at presentation and\/or during the disease course. A small proportion of normal-GGT PFIC is likely not due to<\/jats:bold>\n                      <jats:bold>ATP8B1<\/jats:bold>\n                      <jats:bold>or<\/jats:bold>\n                      <jats:bold>ABCB11<\/jats:bold>\n                      <jats:bold>mutations. (Hepatology 2010)<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.23539","type":"journal-article","created":{"date-parts":[[2010,1,28]],"date-time":"2010-01-28T10:04:48Z","timestamp":1264673088000},"page":"1645-1655","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":268,"title":["Atp8b1 and Abcb11 Analysis in 62 Children With Normal Gamma-Glutamyl Transferase Progressive Familial Intrahepatic Cholestasis (Pfic): Phenotypic Differences Between Pfic1 and Pfic2 and Natural History"],"prefix":"10.1097","volume":"51","author":[{"given":"Anne","family":"Davit-Spraul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Fabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Branchereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Baussan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Stieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Jacquemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20250312","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-4-1","article-title":"Progressive familial intrahepatic cholestasis.","volume":"4","author":"Davit Spraul","year":"2009","journal-title":"Orphanet J Rare Dis"},{"key":"R2-22-20250312","doi-asserted-by":"crossref","first-page":"219224","DOI":"10.1038\/ng0398-219","article-title":"A gene encoding a Ptype ATPase mutated in two forms of hereditary cholestasis.","volume":"18","author":"Bull","year":"1998","journal-title":"Nat Genet"},{"key":"R3-22-20250312","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1002\/hep.20285","article-title":"Characterization of mutations in ATP8B1 associated with hereditary cholestasis.","volume":"40","author":"Klomp","year":"2004","journal-title":"Hepatology"},{"key":"R4-22-20250312","doi-asserted-by":"crossref","first-page":"10601069","DOI":"10.1053\/j.gastro.2008.10.025","article-title":"ATP8B1 disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained.","volume":"136","author":"Cai","year":"2009","journal-title":"Gastroenterology"},{"key":"R5-22-20250312","doi-asserted-by":"crossref","first-page":"233238","DOI":"10.1038\/3034","article-title":"A gene encoding a liverspecific ABC transporter is mutated in progressive familial intrahepatic cholestasis.","volume":"20","author":"Strautnieks","year":"1998","journal-title":"Nat Genet"},{"key":"R6-22-20250312","doi-asserted-by":"crossref","first-page":"379384","DOI":"10.1053\/j.gastro.2004.04.065","article-title":"Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11.","volume":"127","author":"Van Mil","year":"2004","journal-title":"Gastroenterology"},{"key":"R7-22-20250312","doi-asserted-by":"crossref","first-page":"12031214","DOI":"10.1053\/j.gastro.2008.01.038","article-title":"Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families.","volume":"134","author":"Strautnieks","year":"2008","journal-title":"Gastroenterology"},{"key":"R8-22-20250312","doi-asserted-by":"crossref","first-page":"447452","DOI":"10.1016\/S0168-8278(03)00286-1","article-title":"Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: no catchup of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation.","volume":"39","author":"Lykavieris","year":"2003","journal-title":"J Hepatol"},{"key":"R9-22-20250312","doi-asserted-by":"crossref","first-page":"13701379","DOI":"10.1016\/S0016-5085(99)70287-8","article-title":"Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.","volume":"117","author":"Jansen","year":"1999","journal-title":"Gastroenterology"},{"key":"R10-22-20250312","doi-asserted-by":"crossref","first-page":"119124","DOI":"10.1067\/mpd.2002.119993","article-title":"FIC1 and BSEP defects in Taiwanese patients with chronic intrahepatic cholestasis with low alphaglutamyltranspeptidase levels.","volume":"140","author":"Chen","year":"2002","journal-title":"J Pediatr"},{"key":"R11-22-20250312","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1097\/01.fpc.0000230418.28091.76","article-title":"Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with druginduced liver injury.","volume":"17","author":"Lang","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"R12-22-20250312","first-page":"91102","article-title":"Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance pglycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy.","volume":"14","author":"PauliMagnus","year":"2004","journal-title":"Pharmacogenetics"},{"key":"R13-22-20250312","first-page":"128133","article-title":"Histologic pathology of the liver in progressive familial intrahepatic cholestasis.","volume":"18","author":"Alonso","year":"1994","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R14-22-20250312","first-page":"134141","article-title":"Clinical and biochemical findings in progressive familial intrahepatic cholestasis.","volume":"18","author":"Whitington","year":"1994","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R15-22-20250312","doi-asserted-by":"crossref","first-page":"155164","DOI":"10.1002\/hep.510260121","article-title":"Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease PFIC1 and Byler syndrome): evidence for heterogeneity.","volume":"26","author":"Bull","year":"1997","journal-title":"Hepatology"},{"key":"R16-22-20250312","doi-asserted-by":"crossref","first-page":"97099714","DOI":"10.1073\/pnas.0807919106","article-title":"ATP8B1 is essential for maintaining normal hearing.","volume":"106","author":"Stapelbroek","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R17-22-20250312","first-page":"610618","article-title":"Haga H, Tsuruyama T et al. Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation.","volume":"15","author":"MyagawaHayashino","year":"2009","journal-title":"Liver Transpl"},{"key":"R18-22-20250312","doi-asserted-by":"crossref","first-page":"251252","DOI":"10.1016\/S0022-3476(87)80079-3","article-title":"Normal glutamyltranspeptidase activity identifies groups of infants with idiopathic cholestasis with poor prognosis.","volume":"111","author":"Maggiore","year":"1987","journal-title":"J Pediatr"},{"key":"R19-22-20250312","doi-asserted-by":"crossref","first-page":"519523","DOI":"10.1002\/hep.510250303","article-title":"Ursodeoycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis.","volume":"25","author":"Jacquemin","year":"1997","journal-title":"Hepatology"},{"key":"R20-22-20250312","doi-asserted-by":"crossref","first-page":"424428","DOI":"10.1007\/BF01983406","article-title":"Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestasis (Byler disease).","volume":"153","author":"Jacquemin","year":"1994","journal-title":"Eur J Pediatr"},{"key":"R21-22-20250312","doi-asserted-by":"crossref","first-page":"10131016","DOI":"10.1016\/0016-5085(90)90027-X","article-title":"Rifampin relieves pruritus in children with cholestatic liver disease.","volume":"98","author":"Cynamon","year":"1990","journal-title":"Gastroenterology"},{"key":"R22-22-20250312","doi-asserted-by":"crossref","first-page":"16351641","DOI":"10.1016\/0022-3468(95)90440-9","article-title":"Selective surgical management of progressive familial intrahepatic cholestasis (Bylers disease).","volume":"30","author":"Emond","year":"1995","journal-title":"J Pediatr Surg"},{"key":"R23-22-20250312","doi-asserted-by":"crossref","first-page":"975982","DOI":"10.1002\/humu.20765","article-title":"Evaluation of in silico tools for decision making in molecular diagnosis.","volume":"29","author":"Houdayer","year":"2008","journal-title":"Hum Mut"},{"key":"R24-22-20250312","doi-asserted-by":"crossref","first-page":"16591666","DOI":"10.1053\/gast.2002.36587","article-title":"Functional expression of the canalicular bile salt export pump of human liver.","volume":"123","author":"Noe","year":"2002","journal-title":"Gastroenterology"},{"key":"R25-22-20250312","doi-asserted-by":"crossref","first-page":"14481458","DOI":"10.1053\/gast.2001.23984","article-title":"The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood.","volume":"120","author":"Jacquemin","year":"2001","journal-title":"Gastroenterology"},{"key":"R26-22-20250312","doi-asserted-by":"crossref","first-page":"553567","DOI":"10.1002\/hep.22683","article-title":"Missense mutations and single nucleotide polymorphisms in ABCB11 impair BSEP processing and function or disrupt premRNA splicing.","volume":"49","author":"Byrne","year":"2009","journal-title":"Hepatology"},{"key":"R27-22-20250312","doi-asserted-by":"crossref","first-page":"570574","DOI":"10.1111\/j.1399-3046.2006.00524.x","article-title":"Safety of livingrelated liver transplantation for progressive familial intrahepatic cholestasis.","volume":"10","author":"Cutillo","year":"2006","journal-title":"Pediatr Transpl"},{"key":"R28-22-20250312","doi-asserted-by":"crossref","first-page":"219224","DOI":"10.1034\/j.1399-3046.1999.00046.x","article-title":"Treatment of progressive familial intrahepatic cholestasis: liver transplantation or partial external biliary diversion.","volume":"3","author":"Ismail","year":"1999","journal-title":"Pediatr Transpl"},{"key":"R29-22-20250312","doi-asserted-by":"crossref","first-page":"13121320","DOI":"10.1016\/j.jpedsurg.2007.10.055","article-title":"Preoperative observations and shortterm outcome after partial external biliary diversion in 13 patients with progressive familial intrahepatic cholestasis.","volume":"43","author":"Arnell","year":"2008","journal-title":"J Pediatr Surg"},{"key":"R30-22-20250312","doi-asserted-by":"crossref","first-page":"216221","DOI":"10.1097\/MPG.0b013e31819a4e3d","article-title":"Partial external biliary diversion in children with progressive familial intrahepatic cholestasis and Alagille disease.","volume":"49","author":"Yang","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R31-22-20250312","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-230X-8-47","article-title":"Bile composition in Alagille syndrome and PFIC patients having partial external biliary diversion.","volume":"8","author":"Emerick","year":"2008","journal-title":"BMC Gastroenterol"},{"key":"R32-22-20250312","doi-asserted-by":"crossref","first-page":"15061516","DOI":"10.1002\/hep.21630","article-title":"4Phenylbutyrate enhances the cell surface expression and the transport capacity of wildtype and mutated bile salt export pumps.","volume":"45","author":"Hayashi","year":"2007","journal-title":"Hepatology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.23539","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201005000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T07:12:13Z","timestamp":1741763533000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201005000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.23539","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}